These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2412062)

  • 1. Effects of serotonin on the cardiopulmonary circulatory system with and without 5-HT2-receptor blockade by ketanserin.
    Breuer J; Meschig R; Breuer HW; Arnold G
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S64-6. PubMed ID: 2412062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular effects of ketanserin in closed-chest anesthetized dogs.
    van de Water A; Wouters L; Xhonneux R; Reneman S
    Arch Int Pharmacodyn Ther; 1985 Jun; 275(2):267-78. PubMed ID: 3161481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin-induced vasoconstriction in the perfused canine femoral artery can be blocked in vivo by ketanserin.
    Meschig R; Breuer J; Arnold G
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S56-9. PubMed ID: 2412060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary vascular effects of serotonin and selective serotonin reuptake inhibitors in the late-gestation ovine fetus.
    Delaney C; Gien J; Grover TR; Roe G; Abman SH
    Am J Physiol Lung Cell Mol Physiol; 2011 Dec; 301(6):L937-44. PubMed ID: 21908589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketanserin prevents platelet aggregation and endotoxin-induced pulmonary vasoconstriction.
    Meuleman TR; Hill DC; Port JD; Stanley TH; Pace NL; Mohammad SF
    Crit Care Med; 1983 Aug; 11(8):606-11. PubMed ID: 6872549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular and blood gas responses to ketanserin in canine pulmonary edema induced by oleic acid.
    Koyama S; Kiyono S; Kayaba K; Kimura M; Nishizawa M
    Anesthesiology; 1985 Apr; 62(4):457-61. PubMed ID: 3157333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic benefits of 5-hydroxytryptamine inhibition following pulmonary embolism.
    Huval WV; Mathieson MA; Stemp LI; Dunham BM; Jones AG; Shepro D; Hechtman HB
    Ann Surg; 1983 Feb; 197(2):220-5. PubMed ID: 6824376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dexfenfluramine on hypoxic pulmonary vasoconstriction and embolic pulmonary hypertension in dogs.
    Naeije R; Wauthy P; Maggiorini M; Leeman M; Delcroix M
    Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 1):692-7. PubMed ID: 7881658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonergic mechanisms and blood pressure in sheep.
    Nelson MA; Coghlan JP; Denton DA; Mills EH; Scoggins BA; Spence CD; Whitworth JA
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S117-9. PubMed ID: 2412029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redistribution of carotid artery blood flow by 5-HT: effects of the 5-HT2 receptor antagonists ketanserin and Wal 1307.
    Verdouw PD; Jennewein HM; Heiligers J; Duncker DJ; Saxena PR
    Eur J Pharmacol; 1984 Jul; 102(3-4):499-509. PubMed ID: 6548449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of 5-hydroxytryptamine in the control of pulmonary vascular tone in a rabbit model of pulmonary hypertension secondary to left ventricular dysfunction.
    Deuchar GA; Hicks MN; MacLean MR
    Pulm Pharmacol Ther; 2005; 18(1):23-31. PubMed ID: 15607124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Carboxamidotryptamine is a selective agonist at 5-hydroxytryptamine receptors mediating vasodilatation and tachycardia in anaesthetized cats.
    Connor HE; Feniuk W; Humphrey PP; Perren MJ
    Br J Pharmacol; 1986 Feb; 87(2):417-26. PubMed ID: 2937503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketanserin causes surmountable antagonism of 5-hydroxytryptamine-induced contractions of large coronary arteries of dog.
    Frenken M; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan; 328(3):301-3. PubMed ID: 3157065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of 5-HT2 receptor inhibition in pulmonary embolization.
    Thompson JA; Millen JE; Glauser FL; Hess ML
    Circ Shock; 1986; 20(4):299-309. PubMed ID: 3791578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition by ketanserin of serotonin induced cerebral arteriolar constriction.
    Thompson JA; Wei EP; Kontos HA
    Stroke; 1984; 15(6):1021-4. PubMed ID: 6506113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tryptaminergic receptors in the bovine pulmonary vasculature: effects of ketanserin.
    Ogunbiyi PO; Eyre P
    Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):31-55. PubMed ID: 6328601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin contributes to high pulmonary vascular tone in a sheep model of persistent pulmonary hypertension of the newborn.
    Delaney C; Gien J; Roe G; Isenberg N; Kailey J; Abman SH
    Am J Physiol Lung Cell Mol Physiol; 2013 Jun; 304(12):L894-901. PubMed ID: 23605003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of increased lung serotonin levels to endotoxin-induced pulmonary hypertension in sheep. Effect of a serotonin antagonist.
    Demling RH; Wong C; Fox R; Hechtman H; Huval W
    Am Rev Respir Dis; 1985 Dec; 132(6):1257-61. PubMed ID: 2934013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist.
    Wenting GJ; Man in 't Veld AJ; Woittiez AJ; Boomsma F; Schalekamp MA
    Br Med J (Clin Res Ed); 1982 Feb; 284(6315):537-9. PubMed ID: 6800533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular profile and hypotensive mechanism of ketanserin in the rabbit.
    Bolt GR; Saxena PR
    Hypertension; 1985; 7(4):499-506. PubMed ID: 2861161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.